An Experimental Drug Discovered Could Cure Cancer

In a small clinical trial conducted in the USA, it was discovered that an experimental cancer drug could cure cancer patients. According to a study published in The New England Journal of Medicine, 12 patients, all diagnosed with rectal cancer, Dostarlimab over a six-month period (experimental drug) after receiving entered the healing process.

One of the lead authors of the journal, Dr. Luis Diaz told The New York Times, “This is the first time in the history of cancer treatment“Although the scientists are excited about the research, they are hopeful for the results to come out,” he said. More experiments need to be done and cautioned against concluding that the cancer was permanently eradicated. Let’s take a look at the details together.

After a 2-year period in the experiment, the cancer cells were completely destroyed.

Dostarlimab, in the treatment of endometrial cancer It is an immune system therapy drug used in rectal cancer It was the first clinical study to determine whether it could be effective against tumours. The drug unmasks cancer cells, allowing the immune system to identify and destroy them.

12 patients for six months for the study received dostarlimab every three weeks. Normally, this treatment would be followed by standard chemotherapy and surgery, but it was concluded that this was not necessary with the feedback received from the patients.

Six months after patients stop taking the drug, cancer cells can be detected by physical examination, endoscopy, PET or MRI scans. disappeared undetected. Two years after the study, patients recovered from cancer. seems to have completely recovered. As a result, none of the participants in the study have yet did not undergo chemotherapy or surgery. What are you thinking? Please do not forget to share your thoughts with us in the comments.